Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 91.7 USD -0.09% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Capital Expenditures Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Capital Expenditures
-$53.8m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
7%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Capital Expenditures
-$169m
CAGR 3-Years
-10%
CAGR 5-Years
-4%
CAGR 10-Years
-5%
ICU Medical Inc
NASDAQ:ICUI
Capital Expenditures
-$97.3m
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-17%
Align Technology Inc
NASDAQ:ALGN
Capital Expenditures
-$117.8m
CAGR 3-Years
30%
CAGR 5-Years
6%
CAGR 10-Years
-19%
Lantheus Holdings Inc
NASDAQ:LNTH
Capital Expenditures
-$120.7m
CAGR 3-Years
-120%
CAGR 5-Years
-37%
CAGR 10-Years
-34%
Merit Medical Systems Inc
NASDAQ:MMSI
Capital Expenditures
-$43.3m
CAGR 3-Years
-10%
CAGR 5-Years
11%
CAGR 10-Years
-1%

See Also

What is Haemonetics Corp's Capital Expenditures?
Capital Expenditures
-53.8m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Capital Expenditures amounts to -53.8m USD.

What is Haemonetics Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
7%

Over the last year, the Capital Expenditures growth was 15%. The average annual Capital Expenditures growth rates for Haemonetics Corp have been 1% over the past three years , 2% over the past five years , and 7% over the past ten years .

Back to Top